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O bjectives:  T o  i n v e s t i g a t e  w h e t h e r  m o d e l l i n g  t e c h n i q u e s  c a n  b e  u s e d  i n  t h e  p l a n n i n g  o f  h e a l t h  c a r e  f a c i l i t i e s  F o r
p a t i e n t s  r e q u i r i n g  n e o n a t a l  e x t r a c o r p o  r e a l  m e m b r a n e  o x y g e n a t i o n  ( E C M O ) .
M e th o d s : I n  a  m i c r o - s i m u l a t i o n  m o d e l  t h e  n u m b e r  o f  p a t i e n t s  t h a t  w i l l  h a v e  t o  b e  r e f e r r e d  t o  f a c i l i t i e s  a b r o a d  is  
e s t i m a t e d  f o r  a n y  n u m b e r  o f  n e o n a t a l  E C M O  p a t i e n t s  p r e s e n t i n g  a n n u a l l y  f o r  t r e a t m e n t  i n  T h e  N e t h e r l a n d s ,  a n d  a n y  
n u m b e r  o f  E C M O  f a c i l i t i e s .  T h e  i n p u t s  t o  t h e  m o d e l  c o n s i s t  o f  t h e  n u m b e r  o f  E C M O  f a c i l i t i e s ,  t h e  n u m b e r  o f  
p a t i e n t s  p r e s e n t i n g  a n n u a l l y ,  t h e  d u r a t i o n  o f  t r e a t m e n t  a n d  t h e  d a t e  o n  w h i c h  p a t i e n t s  p r e s e n t  f o r  E C M O  t r e a t m e n t .  
T h e  m o d e l  is  e s t i m a t e d  o n  d a t a  f r o m  T h e  N e t h e r l a n d s  f o r  1 9 9 2 ,  d u r i n g  w h i c h  2 9  p a t i e n t s  w e r e  t r e a t e d  i n  t h r e e  f a c i l ­
i t i e s .  S e v e r a l  f u t u r e  s c e n a r i o s  a r e  m o d e l l e d ,  p r i n c i p a l l y  o n e  i n  w h i c h  a  p o t e n t i a l  i n c r e a s e  t o  5 6  p a t i e n t s  p e r  y e a r  is  
f o r e s e e n .
R esu lts :  T h e  m o d e l  i n d i c a t e s  t h a t ,  i f  s u c h  a n  i n c r e a s e  t a k e s  p l a c e ,  n o  a d d i t i o n a l  E C M O  f a c i l i t i e s  w i l l  b e  n e c e s s a r y  
i n  T h e  N e t h e r l a n d s  i f  b e t w e e n  t h r e e  a n d  f o u r  r e f e r r a l s  a n n u a l l y  t o  c e n t r e s  o u t s i d e  t h e  r e g i o n  ( o r  a b r o a d )  a r e  
c o n s i d e r e d  a c c e p t a b l e  a n d  f e a s i b l e .  I n  t h a t  s i t u a t i o n ,  i t  i s  e x p e c t e d  t h a t  o n  2 2  o c c a s i o n s  e a c h  y e a r  t w o  p a t i e n t s  w i l l  b e  
t r e a t e d  s i m u l t a n e o u s l y ,  f o r  a  t o t a l  o f  8 1  d a y s .  O n  t e n  o c c a s i o n s ,  a l l  t h r e e  f a c i l i t i e s  w i l l  b e  o c c u p i e d  a t  t h e  s a m e  t i m e ,  
f o r  2 1  d a y s  i n  t o t a l .  O n  1 9 9  d a y s ,  a t  l e a s t  o n e  o f  t h e  f a c i l i t i e s  w i l l  b e  o c c u p i e d .
Conclusion:  T h e  c u r r e n t  s t u d y  s h o w s  t h a t  t h e  a c c e p t a b i l i t y  a n d  f e a s i b i l i t y  o f  p a t i e n t  r e f e r r a l s  t o  E C M O  c e n t r e s  
a b r o a d  i s  a n  i m p o r t a n t  i s s u e  w h i c h  h e a l t h  c a r e  p l a n n e r s  w i l l  h a v e  t o  c o n s i d e r .  T h e  s t u d y  a l s o  s h o w s  t h a t  m o d e l l i n g  
t e c h n i q u e s  c a n  p r o v i d e  i n f o r m a t i o n  t h a t  i s  u s e f u l  t o  p o l i c y - m a k e r s  i n  t h e  p l a n n i n g  o f  h e a l t h  c a r e  f a c i l i t i e s .
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Introduction
Extracorporeal membrane oxygenation (ECMO) is one  
of the new technologies in neonatal intensive care, it is 
a device which is potentially life-saving for neonates with
anticoagulant treatment.1’" Therefore, ECMO treatment 
is generally limited to those who are thought: to have 
a high risk of death with conservative treatment (a pre­
dicted survival of 20% or less) and a low risk of rom-
reversible respiratory diseases due Lo various causes. By Phcat,° " s ™ Ú' 1'C[¡4°  (e*  a b,rth^ ,U o l 2000 «Ta'"s 
temporarily taking over the function of the lungs and ° ^ m ore)’'I" *or thcse P»0 ?“ *  ^ CMO “P I ™ .  ,<). 1,r 
heart, ECMO can give diseased lungs the opportunity die ^ “ porcai L,ic Sl‘PPort (>KamsaUon
to recover and can avert the pulmonary complications 
that frequently occur if prolonged high-pressure venti­
lation is necessary. However, ECMO itself may induce  
complications, most notably bleeding due to systemic
. i 11
Bowine C . Michel MB PhD, Senior Research Fellow, Ben A. van H o u t
M S cP h D ,  Associate Professor, Institute for Medical Technology 
Assessment, Erasmus University R o tte rdam , The Netherlands.
Rob J .  E« van Staveren MSc, M anaging  Director, D epartm en t  of 
Paediatric Surgery, Rotterdam University I-Iospital/Sophia C h ild rens1 
Hospital, Rotterdam, T he  N e the r lands .  Wil B. Geven MD PhD, 
Associate Professor, D epar tm en t  o f  Neonatology, Nijmegen University 
Hospital, Nijmegen, The N ether lands .  C orrespondence 'to  BCM: 
Institute fo r  Medical Technology Assessment L3-107, Erasmus
University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The 
Netherlands.
(ELSO) reports an overall survival of 80% in 11 000 
neonates treated with ECMO,1’ and recently, in the UK, 
the first large prospective randomised controlled trial on 
ECMO was stopped by the data monitoring committee 
because patients in the ECMO group showed a much 
better survival rate than those treated with intensive 
conservative therapy.7 Reports on the quality of life after 
ECMO so far are also favourable. Even though a recently 
published long-term follow-up study did indicate that 
ECMO survivors may have an increased risk o í behav­
ioural problems and academic difficili ties at the age of
5 years compared to patients surviving after conserva­
tive treatment,8 in general, equal or less neurological 
and psychomotor dysfunction is reported for ECMO 
survivors than for those managed conservatively.'1,10
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Neonatal ECMO has been introducted differently 
in various countries. In the USA, ECMO is already an 
accepted form of therapy for high-risk neonates.9,11 In 
Europe, the introduction of ECMO is on going. Since 
1987, ECMO centres have been founded in Germany,
France and Sweden among others.12,13 In the UK, ECMO 
was introduced in the context of a randomised con­
trolled trial,7,14 In The Netherlands, the attitude towards 
neonatal ECMO has also been cautious. Up to 1995, 
there were three centres in operation, all waiting for a 
definite decision on their future status by the health care 
authorities.
Once the health care authorities in a country ap­
prove the use of ECMO, they also have to decide on the 
number of ECMO facilities that are necessary to provide 
adequate care. Additionally, in a region where ECMO 
is already an established therapy it may be necessary to 
adjust the number of ECMO facilities if changes in the 
indications for this treatment occur. It is to be expected 
that the required number of facilities in a region will 
depend on the number of patients who fulfil the 
indications for ECMO, the average duration of ECMO 
treatment and the occurrence of simultaneous patient 
presentation. Therefore, for any given number of 
ECMO facilities, momentary over- or under-capacity may 
occur. Since ECMO is a potentially life-saving treatment, 
patients who cannot be treated at moments of under­
capacity will either have to be treated conservatively -  
with almost certainly a lower survival probability « or be 
referred to ECMO centres elsewhere. Whether or not 
such referrals are feasible and desirable are questions Figure 1 Outline of the simulation model, 
that will not be addressed in this article. Here, we con™
,>iv «
child presented for 
ECMO
V.
-----■> . I. . I.ilt» !*  -
f transfer to ECMO A 
facility
S '  \
transfer to ECMO facility 
abroad/outside region
ECMO facility occupied 
for treatment duration
transition of the model to the 'l 
next child being presented
for ECMO
r  W" V** « •
..................... — a
ECMO facility occupied 
for 4 hours cleaning
ECMO facility free
centrate on the consequences o f the establishment of 
various numbers of ECMO facilities in The Netherlands, 
The approach followed is generally applicable to any 
region in any country with the same number of patients 
requiring ECMO treatment, similar indications and the 
same distribution of ECMO treatment durations. Addi­
tionally, if one of the above variables is different from 




presenting annually; the duration of treatment; and the 
day of the year patients present for ECMO treatment. 
First, a baseline analysis is performed, describing the 
situation in The Netherlands in 1992. Then, several 
alternative scenarios are formulated to study the effects 
of plausible future events on the number of ECMO 
facilities required. Finally, a sensitivity analysis for the 
main variable, duration of treatment, is performed.
Model estimation
The baseline analysis is based on real data for The 
Netherlands. In 1992, three ECMO centres were func­
tioning in The Netherlands. Two centres, in Rotterdam
The model describes a process o f events after a seriously and Nijmegen, included patients strictly according to
ill newborn child has been admitted to a Dutch hospital. a common research protocol, limiting treatment to
If the child needs ECMO treatment, and if there are neonatal patients with an AaDO, above 600 mmHg for
no contraindications, the availability of an ECMO facility 8 hours, or an Oxygenation Index above 40 in three
is assessed. If an ECMO facility is available the child to five consecutive blood gas samples within 5 hours,
will be transferred to that facility, otherwise the child Patients with serious heart disease, causing an important
will be transferred to a facility abroad (Fig. 1).
In the model, the number of ECMO facilities re­
quired to treat various numbers of patients is estimated 
by simulating ECMO treatments for 1000 separate years 
and more than 1.8 million individual patients in a 
discrete event micro-simulation model (Figure 1). The 
micro-simulation model is based on four variables: the 
number of ECMO facilities; the number of patients
right to left shunting, were excluded. The third facility, 
in Maastricht, did not follow an official protocol. For 
this centre, data were only included on the five patients 
who would have fulfilled the entry criteria used by the 
other two centres. Patients treated between January 1991 
and July 1993 were used for the estimation procedure. 
The main characteristics of these patients are described 
in Table 1.
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Table 1 Characteristics of the 53 patients trea ted  between 
January 1991 and July 1993
Characteristics
Diagnosis'
Congenital diaphragmatic herma 
Meconium aspiration syndrome 
Other
Gestational age in weeks"
Birth weight in grams1'
Hours on ECMO!i
Hours between birth and ECMO;;
“ Number of patients {%). 





39.4 ± 1.8 
3325 ± 523 
144 ± 7 3  
45 ± 5 5
micro-simulation model differ slightIv from the observed
O
filiures, which are shown in the fourth column, hut all
o
observed figures fall within the minimum-maximum  
range o f the results estimated by the model. However, 
caution should be taken in comparing the estimates 
with the observed figures because no record was kept 
of the referrals to centres abroad.
The mean treatment duration for these patients was
6 days with a minimum of 0.6 days and a maximum of
s  *
15 days. For the model the actual distribution of these 
times was used to simulate the duration of treatment
Alternative scenarios
Because ECMO was a new medical treatment facility 
in The Netherlands, referral policy for this treatment 
was probably still suboptimal in 1992. Also, it can be 
expected that inclusion criteria will widen and contra- 
indications will narrow with time. Therefore, the number 
of treatments per year will probably rise, If the 29 treat­
ments in 1992 are related to the 196 734 live births that 
láfor each patient. Four hours were added to the dura- year/ 3 one ECMO treatment per 6784 live births was 
tion of treatment, representing the minimum period performed. Estimates based on the ELSO registry tend
necessary for cleaning and priming the equipment. Pa­
tients were said to be treated simultaneously if any part
to a higher rate o f ECMO treatments: on e in 3859 live 
births in 1988.u Investigators in Georgia, Michigan and
of their treatment period, including the cleaning period, Oregon/W ashington estimated the need for ECMO in
overlapped with the same period of any other patient.
For each patient the model simulated the date of 
birth according to the monthly distribution of births 
in The Netherlands in 1992.1:1 Here the assumption was 
made that ECMO indications themselves showed no 
separate seasonal trend. As a matter o f convenience, the 
date of birth was used as an approximation of the day 
of presentation for treatment, because patients were 
treated with ECMO within an average of 1.9 days (range 
0-15 days) after birth.
Results
In the baseline analysis, 29 patients per year are treated 
in three facilities, as was the situation in The Nether­
lands in 1992. The model shows that die three facilities 
will on average be occupied for 58 days per year if 
patients are evenly spread over the facilities. The other 
results from the simulations are summarised in the first
the same magnitude: one in 3717, one in 3431 and one 
in 3521 births r e s p e c t iv e ly .T h e  need for ECMO in 
the UK has been estimated at approximately one in 
5ÖÖÖ live births.1'
If these estimates apply to the Dutch situation -  
after the treatment has becom e current practice -  the 
number o f treatments will rise to 39 (one in 5000 live 
births) or maybe even to 56 (one in 3500 live births) per 
year, and, o f course, the number o f ECMO facilities 
will have to be adapted to this new situation. In the 
alternative scenarios account is taken o f  these changes.
The separate scenarios simulate the effects o f a 
change in the number o f neonatal patients annually 
presenting for treatment, or a change in the number of  
facilities, or botii. It is assumed that there is no change 
in the average duration o f  treatment or in the distri­
bution o f treatment durations. As may be expected, the 
number o f occasions on which patients require treat­
ment at the same time incitases with the number of
three columns o f Table 2. The estimates based on the patients presenting per year.
Table 2 Results of the simulation model predicted for 1992 compared to the observed events in 1992, and several alternative 
scenarios
1992 situation Alternative scenarios









average min max obs average average average
Patients referred for treatment abroad 0.2 0 2 NA 3.5 0.8 0.0
Occasions patients treated simultaneously (after referral)
2 simultaneous 8.6 4 13 10 21.7 20.9 20.7
3 simultaneous 2.0 0 6 0 9.5 9.4 9.5
4 simultaneous 3.0 2.9
5 simultaneous
Days at least 1 patient is treated 137.5 108 173 168 198.2 202.3 203.5
Days patients are treated simultaneously
2 simultaneous 31.3 7 62 32 80.7 78.0 77.8
3 simultaneous 4.8 0 17 0 20.9 20.8 20.4
4 simultaneous 4.9 4.4
5 simultaneous 0.7
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no. patients requiring treatment
Figure 2 The number of occasions two to six patients will be 
treated at the same time related to the number of patients 
requiring treatment annually in a situation with an unlimited 
number of ECMO facilities.
Figure 2 shows that, even if 60 patients fulfil the 
ECMO criteria annually, there would hardly ever he an 
occasion on which six patients would need treatment 
at the same time. However, the assumption that an un­
limited number of facilities will be available does not 
seem realistic. If the number of treatment facilities is 
limited, some patients will have to be referred to facil­
ities abroad, or be treated conservatively. Depending
\ Facáíy




6 8 10 12 14 16 18 20 22 24 25 28 30 32 34 35 38 40 42 44 48 48 50 52 54 56 58 60
no of patients snnua&y reqy*rir*g ECMO treatment
Figure 3 The percentage of patients that will have to be 
referred to ECMO centres outside the region, if 1-5 facilities are 
available in the region and 6-60 patients require treatment 
annually.
on the number of facilities and the number of patients 
requiring treatment annually, it is estimated that be­
tween zero and 30 patients will have to be referred to 
facilities abroad (see Figure 3). If only one facility is 
established while 60 patients present annually, as many 
as 50% of the patients presenting to that facility will 
have to be referred abroad. In Figure 4, the number 
of occasions on which patients will have to be seated  
simultaneously is shown for two to 60 patients requiring 
treatment annually and for two to five ECMO facilities.
4
Facing an increase to 56 patients annually (one in
2 facilities 3 facilities
6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60
no. patients requiring ECMO
6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 61 54 57 60
no. patients requiring ECMO
4 facilities 5 facilities
6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60
no. patients requiring ECMO
6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60
no. patients requiring ECMO
Figure 4  The number of occasions two to five patients will be treated simultaneously, if 2-5 facilities are available, related to the 
number of patients annually requiring treatment. Patients that are referred to centres outside the region are included in the number 
of patients annually requiring treatment but excluded from the patients treated simultaneously.
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3521 births), Du ah  health care planners can deride to 
leave die number oí fad lilies unchanged or expand io 
four or five lac ili lies.
Table 2 shows the consequences o f these scenarios. 
An expansion from three to four facilities will diminish 
the number o f  referrals abroad from 3.5 to 0.8 patients 
on average per vear. It is expected that all four facilities 
would then be occupied at the same time for 4.9 days 
per year. A further expansion to five facilities decreases 
the number o f referrals abroad even more, to less than 
one patient in 10 years. The disadvantage o f such a 
policy is that all centres will be occupied simultaneously 
for only 0.7 days per year.
of patients may lead to higher levels of occupancy of 
the facilities, causing an increase in referrals to facilities 
outside the legion. If the number of ECMO facilities 
is subsequently increased, the number of patients for 
whom facilities have to be found outside the area de­
creases. But, if too many facilities are established, money 
will be spent on facilities that will be left unoccupied 
for most of the year. An ECMO facility costs about
DFL 300 000 ( 1 DEL -  0.58 US$ = £ 0.38 -  0.47 ECU
in June 1996) and initial investments for training of 
specialised personnel, both physicians and nurses, could 
amount to over DFL 50 000. If an ECMO facility is 
left unoccupied for a year, the fixed costs for interest, 
depreciation and maintenance, amounting to roughly 
DFL 70 000 a year, will still have to be met. If an ECMO 
facility is only occupied infrequently the salaries of the 
ECMO personnel will still have to be paid if they cannot 
be temporarily employed elsewhere. But such temporary 
employment may cause problems when an ECMO pa­
tient arrives unexpectedly for urgent treatment. Also, 
the existence of spare capacity could lead to a relaxation 
in the eligibility criteria for ECMO treatment, causing 
increased use by patients who do not need ECMO to 
survive, which in turn decreases the cost-effectiveness 
of the technology. Careful planning of the number of 
facilities may prevent these effects.
Discussion Planning problems in which random processes play a
major role, such as the presentation of ECMO patients,
Although the planning of all health care facilities is can be partially solved by micro-simulation models. Of
advisable, the planning of ECMO facilities is particularly course, models are abstract representations of reality,
Sensitivity analysis
If the average duration of ECMO treatment is increased 
by 1 (16.7%) or 2 days (33.3%) while its distribution re­
mains unchanged, the average number of referrals to 
centres abroad in the 1992 situation increases to an 
average of 0.4 patients per year (i.e. a 100%; increase) or 
0.5 patients (a 150% increase) (see Table 3). However, 
all changes in the average referrals abroad found in 
the sensitivity analysis fall within the range of referrals 
presented in Table 2.
important since the patients involved cannot be placed 
on a waiting list Patients who cannot be treated because
and, as stated by Feest and Harrison, they are only as 
good as the data fed into them.20 But, although they 
of a shortage in facilities in a region will have to be have their limitations, they provide information that 
treated conserv atively or be referred to other regions. can be used in the planning of health care facilities. Most 
Planning is necessary not only when ECMO is intro- of the planning in health care with the aid of in tro­
duced in a region but also when changes in the number 
of patients requiring ECMO occur. Such changes, both 
increases and decreases, could occur through changes 
in the indications for treatment after publication of 
the results of randomised trials, through changes in the 
alternative treatments and through improvements in the 
technique itself.14,18,19 An increase in the annual number
simulation was done for renal services and hospital 
bed requirem ents/^’ Unfortunately, the results were 
mainly published in journals specialising in operational 
research, not read by most health care workers.13,24,25,27
The micro-simulation model for the planning of 
ECMO facilities shows that in The Netherlands -  if there 
is no change in the average duration of treatment -  an













i« rw* •  m
Increase in the duration of treatment in days:5 +1 +2 +1 +2 +1 +2 +1 +2
Patients referred for treatment elsewhere 0.4 0.5 4.0 5.7 1.1 0.9
i . .. .............. .. ■ ■ ■ ■ i i i i
0.2 0.4
Occasions patients treated simultaneously (after referral)
2 simultaneous 9.0 10.4 20.4 20.2 20.7 20.6 20.9 20.3
3 simultaneous 2.5 3.3 11.7 13.9 11.3 12.5 11.5 12.4
4 simultaneous 4.0 4.9 3.6 5.0
5 simultaneous 1.0 1.2
Days at least 1 patient is treated 150.2 166.6 219.8 238.7 224.7 248.7 227.1 241.7
Days patients are treated simultaneously
2 simultaneous 37.0 48.3 89.3 97.4 86,2 92.6 88.9 93,4
3 simultaneous 5.9 8.6 28.4 37.0 28.8 33.6 27.9 37.6
4 simultaneous 7.7 8.6 6.8 9.9
5 simultaneous 1.1 2.0
a+1, an increase of 1 day; +2, an increase of 2 days.
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increase to 56 patients a year can take place without 
an increase in ECMO facilities, if between three and four 
referrals to centres elsewhere are accepted and feasible. 
The acceptability or feasibility of these referrals turn out 
to be crucial points in the planning, because it is not 
clear who is to decide on these issues. If these referrals 
are not accepted or are not feasible, an increase in facil­
ities has to be balanced against an investment in facilities 
which will not be occupied frequently. The model also 
shows that, even after an increase to 56 patients per 
year, the marginal contribution of a fifth facility is very 
small. Due to the geographical spread of facilities and 
the patients, the occupancy rate may increase, but this 
increase will be at the expense of the occupancy rate of 
the other four facilities.
The current model only includes data on the occu­
pancy of facilities. If reliable data on costs and their 
relation to the number of patients are available (e.g. 
the annual number of patients at which additional 
personnel should be hired and trained, and the number 
of additional nurses required if patients are treated 
in two facilities instead of one), the model could be 
extended to include these data. After such extension, 
the model could be used to calculate the costs that 
would have to be incurred to prevent one referral to a 
centre abroad or outside the region, which would give 
another dimension to the discussion on the acceptability 
of referrals abroad. For example, if only fixed costs for 
interest, depreciation and maintenance are taken into 
account, setting up a fourth facility in the scenario with 
56 patients annually would cost approximately DFL 
70 000 annually and would prevent (3.5 -  0.8 =) 2.7 re­
ferrals abroad (Table 2) at an average cost of (70 000/ 
2.7 =) DFL 26 000 per prevented referral in interest, 
depreciation and maintenance of the ECMO equipment 
only. Costs for additional personnel would have to be 
added to this.
In countries with large differences in the geographic 
distribution of padents requiring ECMO treatment 
due to transport problems, geographically remote areas 
or unevenness in the incidence of cases, the model 
cannot be applied to estimate the number of ECMO 
facilities required on a national level, but it can be used 
to estimate the need for ECMO facilities in smaller sub- 
regions with a homogeneous patient distribution. For 
The Netherlands, the geographical distributions of facil­
ities and patients are not very important for planning 
purposes, because it is a small country and newborn 
babies are relatively easily transported in ambulances 
and helicopters. In fact, specialised neonatal care in 
The Netherlands is organised on a national rather than 
on a regional basis, with a central coordinating system.
The current study shows that the acceptability and 
feasibility of referrals to centres outside the region -  or 
abroad -  is an important issue which European health 
care planners will have to consider. The study also 
shows that it is possible to plan the number of ECMO 
facilities required in a region with relatively simple tools. 
Such planning may help ECMO centres in their deci­
sions as to whether or not to invest in extra facilities in a
changing area of health care. The results of the current 
study were used by policy-makers in The Netherlands 
to support their decision to approve the provision of 
neonatal ECMO in onlv two ECMO centres. These
j '
centres provide a total of three ECMO facilities. For 
the time being, the government has put no official limit 
on the number of facilities per centre.
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